A pharmaceutically acceptable salt or solvate of the salt of 5-(5-(2-(3 aminopropoxy)-6-methoxyphenyl) 1H-pyrazol-3-ylamino)pyrazine-2 carbonitrile compound
PK201000325A0Undetermined Publication Date: 2010-04-30ELI LILLY & CO
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201000325
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2010-04-21
- Publication Date
- 2010-04-30
Abstract
The present invention provides a pharmaceutically acceptable salt or solvate of the salt of a compound 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino) pyrazine-2-carbonitrile represented by the formula that inhibits Chk1 and is useful in the treatment of cancer
Need to check novelty before this filing date? Find Prior Art